Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension

ClinicalTrials.gov ID: NCT04518293

Public ClinicalTrials.gov record NCT04518293. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 11:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of GMRx2 (a Single Pill Combination Containing Telmisartan/Amlodipine/Indapamide) Compared to Dual Combinations for the Treatment of Hypertension

Study identification

NCT ID
NCT04518293
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
George Medicines PTY Limited
Industry
Enrollment
1,385 participants

Conditions and interventions

Conditions

Interventions

  • Amlodipine 2.5 mg/indapamide 1.25 mg Drug
  • Telmisartan 20 mg/amlodipine 2.5 mg Drug
  • Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg Drug
  • Telmisartan 20 mg/indapamide 1.25 mg Drug
  • amlodipine 5 mg/indapamide 2.5 mg Drug
  • telmisartan 40 mg/amlodipine 5 mg Drug
  • telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg Drug
  • telmisartan 40 mg/indapamide 2.5 mg Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 8, 2021
Primary completion
Aug 10, 2023
Completion
Aug 31, 2023
Last update posted
Jun 2, 2025

2021 – 2023

United States locations

U.S. sites
31
U.S. states
11
U.S. cities
27
Facility City State ZIP Site status
Elite Clinical Studies Phoenix Arizona 85018
Headlands Research Scottsdale Arizona 85260
Quality of Life Medical & Research Associates Tucson Arizona 85712
Valiance Clinical Research South Gate California 90280
Valiance Clinical Research Tarzana California 91356
Clinical Research of Brandon Brandon Florida 33511
Inpatient Research Clinic Hialeah Florida 33013
Multi-Speciality Research Associates Lake City Florida 32055
Suncoast Research Group Miami Florida 33135
New Horizon Research Center Miami Florida 33165
Ocala Research Institute Ocala Florida 34471
Suncoast Research Associates St. Petersburg Florida 33173
Accel Research St. Petersburg Florida 33709
Precision Research Center Tampa Florida 33603
Meridian Clinical Research Savannah Georgia 31406
Buckhead Primary Care Research Snellville Georgia 30078
Loyola University Maywood Illinois 60153
Meridian Clinical Research Baton Rouge Louisiana 70809
Meridian Clinical Research Endwell New York 13760
Javarra Research Charlotte North Carolina 28210
East Carolina University Greenville North Carolina 27834
The University of Tennessee Health Science Center Memphis Tennessee 38105
ACRC Trials - Southwest Medical Village Austin Texas 78735
ACRC Trials - Premier Family Physicians Austin Texas 78746
ACRC Trials - Family Medicine Associates of Texas Carlton Texas 75010
Synergy Groups Medical Houston Texas 77036
Synergy Groups Medical Houston Texas 77087
Synergy Groups Medical Missouri City Texas 77459
North Hills Medical Research North Richland Hills Texas 76180
ACRC Trials - Village Health Partners Plano Texas 75093
Meridian Clinical Research Portsmouth Virginia 23703

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 58 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04518293, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 2, 2025 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04518293 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →